Oxford Immunotec Global PLC Ret. on equity
What is the Ret. on equity of Oxford Immunotec Global PLC?
The Ret. on equity of Oxford Immunotec Global PLC is -8.19%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to Oxford Immunotec Global PLC
Companies with ret. on equity similar to Oxford Immunotec Global PLC
- iShares Trust - iShares 20+ Year Treasury Bond ETF has Ret. on equity of -8.23%
- boohoo group Plc has Ret. on equity of -8.21%
- Gigamedia has Ret. on equity of -8.21%
- Zscaler Inc has Ret. on equity of -8.20%
- Zhongchang International has Ret. on equity of -8.19%
- China Goldjoy has Ret. on equity of -8.19%
- Oxford Immunotec Global PLC has Ret. on equity of -8.19%
- Witbe SA has Ret. on equity of -8.19%
- OptimizeRx has Ret. on equity of -8.18%
- Avon Rubber Plc has Ret. on equity of -8.18%
- Myriad Genetics has Ret. on equity of -8.18%
- Neometals Ltd has Ret. on equity of -8.17%
- Miko International has Ret. on equity of -8.17%